Stericycle (SRCL)
(Delayed Data from NSDQ)
$61.72 USD
+0.02 (0.03%)
Updated Sep 19, 2024 03:59 PM ET
4-Sell of 5 4
D Value B Growth A Momentum B VGM
Income Statements
Fiscal Year end for Stericycle, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,659 | 2,705 | 2,647 | 2,676 | 3,309 |
Cost Of Goods | 1,645 | 1,679 | 1,630 | 1,622 | 2,134 |
Gross Profit | 1,015 | 1,026 | 1,017 | 1,053 | 1,175 |
Selling & Adminstrative & Depr. & Amort Expenses | 937 | 872 | 945 | 1,021 | 1,386 |
Income After Depreciation & Amortization | 77 | 154 | 72 | 32 | -212 |
Non-Operating Income | 0 | 1 | 0 | -6 | -33 |
Interest Expense | 74 | 76 | 72 | 82 | 118 |
Pretax Income | 3 | 79 | 1 | -56 | -363 |
Income Taxes | 25 | 22 | 28 | 0 | -17 |
Minority Interest | 0 | 1 | 1 | 1 | 1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -21 | 57 | -27 | -56 | -346 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -21 | 56 | -28 | -57 | -347 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 294 | 386 | 296 | 265 | 289 |
Depreciation & Amortization (Cash Flow) | 217 | 233 | 224 | 234 | 501 |
Income After Depreciation & Amortization | 77 | 154 | 72 | 32 | -212 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 92.40 | 92.40 | 91.80 | 91.50 | 91.00 |
Diluted EPS Before Non-Recurring Items | 1.89 | 2.04 | 2.19 | 2.25 | 2.65 |
Diluted Net EPS (GAAP) | -0.23 | 0.61 | -0.30 | -0.63 | -3.81 |
Fiscal Year end for Stericycle, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 661.60 | 664.90 | 652.00 | 653.50 | 669.50 |
Cost Of Goods | 403.60 | 410.00 | 395.20 | 407.80 | 418.40 |
Gross Profit | 258.00 | 254.90 | 256.80 | 245.70 | 251.10 |
SG&A, R&D, and Dept/Amort Expenses | 227.50 | 216.00 | 219.70 | 221.50 | 275.10 |
Income After SG&A, R&D, and Dept/Amort Expenses | 30.50 | 38.90 | 37.10 | 24.20 | -24.00 |
Non-Operating Income | -0.10 | 0.00 | 0.20 | 0.10 | -0.60 |
Interest Expense | 20.50 | 18.40 | 17.00 | 17.40 | 19.10 |
Pretax Income | 9.90 | 20.50 | 20.30 | 6.90 | -43.70 |
Income Taxes | 3.90 | 7.40 | 5.50 | 4.80 | 5.80 |
Minority Interest | 0.00 | 0.00 | -0.10 | 0.10 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 6.00 | 13.10 | 14.80 | 2.10 | -49.50 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 6.00 | 13.10 | 14.90 | 2.00 | -49.50 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 93.00 | 93.00 | 92.80 | 92.90 | 92.50 |
Diluted EPS Before Non-Recurring Items | 0.61 | 0.57 | 0.54 | 0.43 | 0.43 |
Diluted Net EPS (GAAP) | 0.06 | 0.14 | 0.17 | 0.02 | -0.54 |